Generated Narrative: StructureDefinition profile-MedicationKnowledge Name Flags Card. Type Description & Constraints MedicationKnowledge 0..* MedicationKnowledge(4.0.1) Definition of Medication Knowledge #xD; Slices for extension 0..* Extension Extension Slice: Unordered, Open by value:url #xD; extension:identifier 0..* Identifier R5: Business identifier for this medication (new) URL: http://hl7.org/fhir/StructureDefinition/artifact-identifier #xD; extension:author 0..1 ContactDetail R5: Creator or owner of the knowledge or information about the medication (new) URL: http://hl7.org/fhir/StructureDefinition/artifact-author #xD; extension:intendedJurisdiction 0..* CodeableConcept R5: Codes that identify the different jurisdictions for which the information of this resource was created (new) URL: http://hl7.org/fhir/5.0/StructureDefinition/extension-MedicationKnowledge.intendedJurisdiction #xD; extension:storageGuideline 0..* (Complex) R5: How the medication should be stored (new) URL: http://hl7.org/fhir/5.0/StructureDefinition/extension-MedicationKnowledge.storageGuideline #xD; status #xD; Slices for modifierExtension 0..* Slice: Unordered, Open by value:url #xD; modifierExtension:status 0..1 code R5: active | entered-in-error | inactive URL: http://hl7.org/fhir/StructureDefinition/artifact-status Binding: PublicationStatus (required): The lifecycle status of an artifact. #xD; synonym #xD; Slices for extension 0..* Extension Extension Slice: Unordered, Open by value:url #xD; extension:name 0..* string R5: A name associated with the medication being described URL: http://hl7.org/fhir/StructureDefinition/artifact-name #xD; monograph #xD; source #xD; Slices for extension 0..* Extension Extension Slice: Unordered, Open by value:url #xD; extension:source 0..1 Reference(Resource) R5: source additional types URL: http://hl7.org/fhir/StructureDefinition/alternate-reference #xD; ingredient #xD; Slices for extension 0..* Extension Extension Slice: Unordered, Open by value:url #xD; extension:type 0..1 CodeableConcept R5: A code that defines the type of ingredient, active, base, etc (new) URL: http://hl7.org/fhir/5.0/StructureDefinition/extension-MedicationKnowledge.definitional.ingredient.type Binding: R5V3RoleClassIngredientEntityForR4 (0.1.0) (example) #xD; strength #xD; Slices for extension 0..* Extension Extension Slice: Unordered, Open by value:url #xD; extension:strength 0..1 CodeableConcept, Quantity R5: strength additional types URL: http://hl7.org/fhir/5.0/StructureDefinition/extension-MedicationKnowledge.definitional.ingredient.strength Binding: R5MedicationIngredientstrengthForR4 (0.1.0) (example) #xD; cost #xD; Slices for extension 0..* Extension Extension Slice: Unordered, Open by value:url #xD; extension:effectiveDate 0..* Period R5: The date range for which the cost is effective (new) URL: http://hl7.org/fhir/5.0/StructureDefinition/extension-MedicationKnowledge.cost.effectiveDate #xD; cost #xD; Slices for extension 0..* Extension Extension Slice: Unordered, Open by value:url #xD; extension:cost 0..1 CodeableConcept R5: The price or category of the cost of the medication additional types URL: http://hl7.org/fhir/5.0/StructureDefinition/extension-MedicationKnowledge.cost.cost Binding: R5MedicationCostCategoryForR4 (0.1.0) (example): A coded concept defining the category of a medication. #xD; administrationGuidelines #xD; Slices for extension 0..* Extension Extension Slice: Unordered, Open by value:url #xD; extension:dosingGuideline 0..* (Complex) R5: Guidelines for dosage of the medication (new) URL: http://hl7.org/fhir/5.0/StructureDefinition/extension-MedicationKnowledge.indicationGuideline.dosingGuideline #xD; medicineClassification #xD; Slices for extension 0..* Extension Extension Slice: Unordered, Open by value:url #xD; extension:source 0..1 string, uri R5: The source of the classification (new) URL: http://hl7.org/fhir/5.0/StructureDefinition/extension-MedicationKnowledge.medicineClassification.source #xD; packaging #xD; Slices for extension 0..* Extension Extension Slice: Unordered, Open by value:url #xD; extension:cost 0..* (Complex) R5: Cost of the packaged medication (new) URL: http://hl7.org/fhir/5.0/StructureDefinition/extension-MedicationKnowledge.cost #xD; extension:packagedProduct 0..1 Reference(Cross-version Profile for R5.PackagedProductDefinition for use in FHIR R4(0.1.0) | Basic) R5: The packaged medication that is being priced (new) URL: http://hl7.org/fhir/5.0/StructureDefinition/extension-MedicationKnowledge.packaging.packagedProduct #xD; drugCharacteristic #xD; Slices for extension 0..* Extension Extension Slice: Unordered, Open by value:url #xD; extension:definition 0..* Reference(Cross-version Profile for R5.MedicinalProductDefinition for use in FHIR R4(0.1.0) | MedicinalProduct) R5: Definitional resources that provide more information about this medication (new) URL: http://hl7.org/fhir/5.0/StructureDefinition/extension-MedicationKnowledge.definitional.definition #xD; extension:value 0..1 Attachment R5: value additional types URL: http://hl7.org/fhir/5.0/StructureDefinition/extension-MedicationKnowledge.definitional.drugCharacteristic.value #xD; contraindication #xD; Slices for extension 0..* Extension Extension Slice: Unordered, Open by value:url #xD; extension:clinicalUseIssue 0..* Reference(Resource) R5: clinicalUseIssue additional types URL: http://hl7.org/fhir/StructureDefinition/alternate-reference #xD; Documentation for this format
Cross-version Profile for R5.MedicationKnowledge for use in FHIR R4
This cross-version profile allows R5 MedicationKnowledge content to be represented via FHIR R4 MedicationKnowledge resources.
Information about a medication that is used to support knowledge.
If the resource is contained in another resource, it SHALL NOT contain nested Resources
not(parent::f:contained and f:contained)
If the resource is contained in another resource, it SHALL be referred to from elsewhere in the resource or SHALL refer to the containing resource
contained.where((('#'+id in (%resource.descendants().reference | %resource.descendants().as(canonical) | %resource.descendants().as(uri) | %resource.descendants().as(url))) or descendants().where(reference = '#').exists() or descendants().where(as(canonical) = '#').exists() or descendants().where(as(canonical) = '#').exists()).not()).trace('unmatched', id).empty()
not(exists(for $id in f:contained/*/f:id/@value return $contained[not(parent::*/descendant::f:reference/@value=concat('#', $contained/*/id/@value) or descendant::f:reference[@value='#'])]))
If a resource is contained in another resource, it SHALL NOT have a meta.versionId or a meta.lastUpdated
contained.meta.versionId.empty() and contained.meta.lastUpdated.empty()
not(exists(f:contained/*/f:meta/f:versionId)) and not(exists(f:contained/*/f:meta/f:lastUpdated))
If a resource is contained in another resource, it SHALL NOT have a security label
When a resource has no narrative, only systems that fully understand the data can display the resource to a human safely. Including a human readable representation in the resource makes for a much more robust eco-system and cheaper handling of resources by intermediary systems. Some ecosystems restrict distribution of resources to only those systems that do fully understand the resources, and as a consequence implementers may believe that the narrative is superfluous. However experience shows that such eco-systems often open up to new participants over time.
A resource should have narrative for robust management
The logical id of the resource, as used in the URL for the resource. Once assigned, this value never changes.
The only time that a resource does not have an id is when it is being submitted to the server using a create operation.
The metadata about the resource. This is content that is maintained by the infrastructure. Changes to the content might not always be associated with version changes to the resource.
All FHIR elements must have a @value or children
hasValue() or (children().count() > id.count())
A set of rules under which this content was created
A reference to a set of rules that were followed when the resource was constructed, and which must be understood when processing the content. Often, this is a reference to an implementation guide that defines the special rules along with other profiles etc.
Asserting this rule set restricts the content to be only understood by a limited set of trading partners. This inherently limits the usefulness of the data in the long term. However, the existing health eco-system is highly fractured, and not yet ready to define, collect, and exchange data in a generally computable sense. Wherever possible, implementers and/or specification writers should avoid using this element. Often, when used, the URL is a reference to an implementation guide that defines these special rules as part of it's narrative along with other profiles, value sets, etc.
This element is labeled as a modifier because the implicit rules may provide additional knowledge about the resource that modifies it's meaning or interpretation
The base language in which the resource is written.
Language is provided to support indexing and accessibility (typically, services such as text to speech use the language tag). The html language tag in the narrative applies to the narrative. The language tag on the resource may be used to specify the language of other presentations generated from the data in the resource. Not all the content has to be in the base language. The Resource.language should not be assumed to apply to the narrative automatically. If a language is specified, it should it also be specified on the div element in the html (see rules in HTML5 for information about the relationship between xml:lang and the html lang attribute).
Text summary of the resource, for human interpretation
A human-readable narrative that contains a summary of the resource and can be used to represent the content of the resource to a human. The narrative need not encode all the structured data, but is required to contain sufficient detail to make it "clinically safe" for a human to just read the narrative. Resource definitions may define what content should be represented in the narrative to ensure clinical safety.
Contained resources do not have narrative. Resources that are not contained SHOULD have a narrative. In some cases, a resource may only have text with little or no additional discrete data (as long as all minOccurs=1 elements are satisfied). This may be necessary for data from legacy systems where information is captured as a "text blob" or where text is additionally entered raw or narrated and encoded information is added later.
These resources do not have an independent existence apart from the resource that contains them - they cannot be identified independently, and nor can they have their own independent transaction scope.
This should never be done when the content can be identified properly, as once identification is lost, it is extremely difficult (and context dependent) to restore it again. Contained resources may have profiles and tags In their meta elements, but SHALL NOT have security labels.
Must have either extensions or value[x], not both
exists(f:extension)!=exists(f:*[starts-with(local-name(.), "value")])
R5: Business identifier for this medication (new)
R5: `MedicationKnowledge.identifier` (new:Identifier)
Element `MedicationKnowledge.identifier` has a context of MedicationKnowledge based on following the parent source element upwards and mapping to `MedicationKnowledge`. Element `MedicationKnowledge.identifier` has no mapping targets in FHIR R4. Typically, this is because the element has been added (is a new element). An externally-defined extension that has been mapped as the representation of FHIR R5 element `MedicationKnowledge.identifier`: `http://hl7.org/fhir/StructureDefinition/artifact-identifier`. This is a business identifier, not a resource identifier (see discussion).
R5: Creator or owner of the knowledge or information about the medication (new)
R5: `MedicationKnowledge.author` (new:Reference(Organization))
Element `MedicationKnowledge.author` has a context of MedicationKnowledge based on following the parent source element upwards and mapping to `MedicationKnowledge`. Element `MedicationKnowledge.author` has no mapping targets in FHIR R4. Typically, this is because the element has been added (is a new element). An externally-defined extension that has been mapped as the representation of FHIR R5 element `MedicationKnowledge.author`: `http://hl7.org/fhir/StructureDefinition/artifact-author`.
R5: Codes that identify the different jurisdictions for which the information of this resource was created (new)
R5: `MedicationKnowledge.intendedJurisdiction` (new:CodeableConcept)
Element `MedicationKnowledge.intendedJurisdiction` has a context of MedicationKnowledge based on following the parent source element upwards and mapping to `MedicationKnowledge`. Element `MedicationKnowledge.intendedJurisdiction` has no mapping targets in FHIR R4. Typically, this is because the element has been added (is a new element). The codes could have varying granularity from a country or group of countries down to a specific district.
exists(f:extension)!=exists(f:*[starts-with(local-name(.), 'value')])
R5: How the medication should be stored (new)
R5: `MedicationKnowledge.storageGuideline` (new:BackboneElement)
Element `MedicationKnowledge.storageGuideline` has a context of MedicationKnowledge based on following the parent source element upwards and mapping to `MedicationKnowledge`. Element `MedicationKnowledge.storageGuideline` has no mapping targets in FHIR R4. Typically, this is because the element has been added (is a new element).
May be used to represent additional information that is not part of the basic definition of the resource and that modifies the understanding of the element that contains it and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer is allowed to define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions. Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).
There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.
Modifier extensions allow for extensions that *cannot* be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the [definition of modifier extensions](http://hl7.org/fhir/R4/extensibility.html#modifierExtension).
Modifier extensions are expected to modify the meaning or interpretation of the resource that contains them
A code that specifies this medication, or a textual description if no code is available. Usage note: This could be a standard medication code such as a code from RxNorm, SNOMED CT, IDMP etc. It could also be a national or local formulary code, optionally with translations to other code systems.
Depending on the context of use, the code that was actually selected by the user (prescriber, dispenser, etc.) will have the coding.userSelected set to true. As described in the coding datatype: "A coding may be marked as a "userSelected" if a user selected the particular coded value in a user interface (e.g. the user selects an item in a pick-list). If a user selected coding exists, it is the preferred choice for performing translations etc. Other codes can only be literal translations to alternative code systems, or codes at a lower level of granularity (e.g. a generic code for a vendor-specific primary one).
A coded concept that defines the type of a medication.
coding.code = //element(*,MedicationType)/DrugCoded/ProductCode coding.system = //element(*,MedicationType)/DrugCoded/ProductCodeQualifier coding.display = //element(*,MedicationType)/DrugDescription
RXO-1.1-Requested Give Code.code / RXE-2.1-Give Code.code / RXD-2.1-Dispense/Give Code.code / RXG-4.1-Give Code.code /RXA-5.1-Administered Code.code / RXC-2.1 Component Code
A code to indicate if the medication is in active use. The status refers to the validity about the information of the medication and not to its medicinal properties.
This status is intended to identify if the medication in a local system is in active use within a drug database or inventory. For example, a pharmacy system may create a new drug file record for a compounded product "ABC Hospital Special Cream" with an active status. At some point in the future, it may be determined that the drug record was created with an error and the status is changed to "entered in error". This status is not intended to specify if a medication is part of a particular formulary. It is possible that the drug record may be referenced by multiple formularies or catalogues and each of those entries would have a separate status.
This element changes the interpretation of all descriptive attributes.
A coded concept defining if the medication is in active use.
unique id for the element within a resource (for internal references)
Additional content defined by implementations
May be used to represent additional information that is not part of the basic definition of the resource. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.
Describes the details of the manufacturer of the medication product. This is not intended to represent the distributor of a medication product.
RXD-20-Substance Manufacturer Name / RXG-21-Substance Manufacturer Name / RXA-17-Substance Manufacturer Name
Describes the form of the item. Powder; tablets; capsule.
When Medication is referenced from MedicationRequest, this is the ordered form. When Medication is referenced within MedicationDispense, this is the dispensed form. When Medication is referenced within MedicationAdministration, this is administered form.
A coded concept defining the form of a medication.
coding.code = //element(*,DrugCodedType)/FormCode coding.system = //element(*,DrugCodedType)/FormSourceCode
RXO-5-Requested Dosage Form / RXE-6-Give Dosage Form / RXD-6-Actual Dosage Form / RXG-8-Give Dosage Form / RXA-8-Administered Dosage Form
Specific amount of the drug in the packaged product. For example, when specifying a product that has the same strength (For example, Insulin glargine 100 unit per mL solution for injection), this attribute provides additional clarification of the package amount (For example, 3 mL, 10mL, etc.).
This is the quantity of medication in a package. To specify the strength of the medication, the Ingredient.strength attribute is used.
Additional names for a medication, for example, the name(s) given to a medication in different countries. For example, acetaminophen and paracetamol or salbutamol and albuterol.
R5: A name associated with the medication being described
Element `MedicationKnowledge.name` is mapped to FHIR R4 element `MedicationKnowledge.synonym` as `Equivalent`. An externally-defined extension that has been mapped as the representation of FHIR R5 element `MedicationKnowledge.name`: `http://hl7.org/fhir/StructureDefinition/artifact-name`.
Associated or related medication information
Associated or related knowledge about a medication.
Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.
May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.
Extensions that cannot be ignored even if unrecognized
May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions. Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).
Modifier extensions are expected to modify the meaning or interpretation of the element that contains them
The category of the associated medication knowledge reference.
Associated documentation about the associated medication knowledge
Associated documentation about the associated medication knowledge.
A medication resource that is associated with this medication
Associated or related medications. For example, if the medication is a branded product (e.g. Crestor), this is the Therapeutic Moeity (e.g. Rosuvastatin) or if this is a generic medication (e.g. Rosuvastatin), this would link to a branded product (e.g. Crestor).
Category of the medication or product (e.g. branded product, therapeutic moeity, generic product, innovator product, etc.).
Associated documentation about the medication
Associated documentation about the medication.
The category of documentation about the medication. (e.g. professional monograph, patient education monograph).
Extensions are always sliced by (at least) url
R5: `MedicationKnowledge.monograph.source` additional types from child elements (display, identifier, reference, type)
Element `MedicationKnowledge.monograph.source` is mapped to FHIR R4 element `MedicationKnowledge.monograph.source` as `SourceIsBroaderThanTarget`. The mappings for `MedicationKnowledge.monograph.source` do not cover the following types based on type expansion: display, identifier, reference, type. The standard extension `alternate-reference` has been mapped as the representation of FHIR R5 element `MedicationKnowledge.monograph.source` with unmapped reference targets: DocumentReference.
Literal reference, Relative, internal or absolute URL
A reference to a location at which the other resource is found. The reference may be a relative reference, in which case it is relative to the service base URL, or an absolute URL that resolves to the location where the resource is found. The reference may be version specific or not. If the reference is not to a FHIR RESTful server, then it should be assumed to be version specific. Internal fragment references (start with '#') refer to contained resources.
Using absolute URLs provides a stable scalable approach suitable for a cloud/web context, while using relative/logical references provides a flexible approach suitable for use when trading across closed eco-system boundaries. Absolute URLs do not need to point to a FHIR RESTful server, though this is the preferred approach. If the URL conforms to the structure "/[type]/[id]" then it should be assumed that the reference is to a FHIR RESTful server.
Type the reference refers to (e.g. "Patient")
The expected type of the target of the reference. If both Reference.type and Reference.reference are populated and Reference.reference is a FHIR URL, both SHALL be consistent. The type is the Canonical URL of Resource Definition that is the type this reference refers to. References are URLs that are relative to http://hl7.org/fhir/StructureDefinition/ e.g. "Patient" is a reference to http://hl7.org/fhir/StructureDefinition/Patient. Absolute URLs are only allowed for logical models (and can only be used in references in logical models, not resources).
This element is used to indicate the type of the target of the reference. This may be used which ever of the other elements are populated (or not). In some cases, the type of the target may be determined by inspection of the reference (e.g. a RESTful URL) or by resolving the target of the reference; if both the type and a reference is provided, the reference SHALL resolve to a resource of the same type as that specified.
Aa resource (or, for logical models, the URI of the logical model).
Logical reference, when literal reference is not known
An identifier for the target resource. This is used when there is no way to reference the other resource directly, either because the entity it represents is not available through a FHIR server, or because there is no way for the author of the resource to convert a known identifier to an actual location. There is no requirement that a Reference.identifier point to something that is actually exposed as a FHIR instance, but it SHALL point to a business concept that would be expected to be exposed as a FHIR instance, and that instance would need to be of a FHIR resource type allowed by the reference.
When an identifier is provided in place of a reference, any system processing the reference will only be able to resolve the identifier to a reference if it understands the business context in which the identifier is used. Sometimes this is global (e.g. a national identifier) but often it is not. For this reason, none of the useful mechanisms described for working with references (e.g. chaining, includes) are possible, nor should servers be expected to be able resolve the reference. Servers may accept an identifier based reference untouched, resolve it, and/or reject it - see CapabilityStatement.rest.resource.referencePolicy. When both an identifier and a literal reference are provided, the literal reference is preferred. Applications processing the resource are allowed - but not required - to check that the identifier matches the literal reference Applications converting a logical reference to a literal reference may choose to leave the logical reference present, or remove it. Reference is intended to point to a structure that can potentially be expressed as a FHIR resource, though there is no need for it to exist as an actual FHIR resource instance - except in as much as an application wishes to actual find the target of the reference. The content referred to be the identifier must meet the logical constraints implied by any limitations on what resource types are permitted for the reference. For example, it would not be legitimate to send the identifier for a drug prescription if the type were Reference(Observation|DiagnosticReport). One of the use-cases for Reference.identifier is the situation where no FHIR representation exists (where the type is Reference (Any).
Plain text narrative that identifies the resource in addition to the resource reference.
This is generally not the same as the Resource.text of the referenced resource. The purpose is to identify what's being referenced, not to fully describe it.
Identifies a particular constituent of interest in the product.
R5: A code that defines the type of ingredient, active, base, etc (new)
R5: `MedicationKnowledge.definitional.ingredient.type` (new:CodeableConcept)
Element `MedicationKnowledge.definitional.ingredient.type` has a context of MedicationKnowledge.ingredient based on following the parent source element upwards and mapping to `MedicationKnowledge`. Element `MedicationKnowledge.definitional.ingredient.type` has no mapping targets in FHIR R4. Typically, this is because the element has been added (is a new element).
Medication(s) or substance(s) contained in the medication
The actual ingredient - either a substance (simple ingredient) or another medication.
RXC-2-Component Code if medication: RXO-1-Requested Give Code / RXE-2-Give Code / RXD-2-Dispense/Give Code / RXG-4-Give Code / RXA-5-Administered Code
Indication of whether this ingredient affects the therapeutic action of the drug.
True indicates that the ingredient affects the therapeutic action of the drug (i.e. active). False indicates that the ingredient does not affect the therapeutic action of the drug (i.e. inactive).
Specifies how many (or how much) of the items there are in this Medication. For example, 250 mg per tablet. This is expressed as a ratio where the numerator is 250mg and the denominator is 1 tablet.
RXC-3-Component Amount & RXC-4-Component Units if medication: RXO-2-Requested Give Amount - Minimum & RXO-4-Requested Give Units / RXO-3-Requested Give Amount - Maximum & RXO-4-Requested Give Units / RXO-11-Requested Dispense Amount & RXO-12-Requested Dispense Units / RXE-3-Give Amount - Minimum & RXE-5-Give Units / RXE-4-Give Amount - Maximum & RXE-5-Give Units / RXE-10-Dispense Amount & RXE-10-Dispense Units
R5: `MedicationKnowledge.definitional.ingredient.strength[x]` additional types (CodeableConcept, Quantity)
Element `MedicationKnowledge.definitional.ingredient.strength[x]` is mapped to FHIR R4 element `MedicationKnowledge.ingredient.strength` as `SourceIsBroaderThanTarget`. The mappings for `MedicationKnowledge.definitional.ingredient.strength[x]` do not cover the following types: CodeableConcept, Quantity.
The instructions for preparing the medication
The instructions for preparing the medication.
The intended or approved route of administration
The intended or approved route of administration.
A coded concept defining the intended route of administration.
R5: The date range for which the cost is effective (new)
R5: `MedicationKnowledge.cost.effectiveDate` (new:Period)
Element `MedicationKnowledge.cost.effectiveDate` has a context of MedicationKnowledge.cost based on following the parent source element upwards and mapping to `MedicationKnowledge`. Element `MedicationKnowledge.cost.effectiveDate` has no mapping targets in FHIR R4. Typically, this is because the element has been added (is a new element).
The category of the cost information. For example, manufacturers' cost, patient cost, claim reimbursement cost, actual acquisition cost.
The source or owner for the price information
The source or owner that assigns the price to the medication.
R5: The price or category of the cost of the medication additional types
R5: `MedicationKnowledge.cost.cost[x]` additional types (CodeableConcept) additional types from child elements (coding, text)
Element `MedicationKnowledge.cost.cost[x]` is mapped to FHIR R4 element `MedicationKnowledge.cost.cost` as `SourceIsBroaderThanTarget`. The mappings for `MedicationKnowledge.cost.cost[x]` do not cover the following types: CodeableConcept. The mappings for `MedicationKnowledge.cost.cost[x]` do not cover the following types based on type expansion: coding, text.
Numerical value (with implicit precision)
Numerical value (with implicit precision).
Monetary values have their own rules for handling precision (refer to standard accounting text books).
The amount of the currency. The value includes an implicit precision in the presentation of the value.
A code indicating the currency, taken from ISO 4217.
Program under which a medication is reviewed
The program under which the medication is reviewed.
Type of program under which the medication is monitored
Type of program under which the medication is monitored.
Guidelines for administration of the medication
Guidelines for the administration of the medication.
R5: Guidelines for dosage of the medication (new)
R5: `MedicationKnowledge.indicationGuideline.dosingGuideline` (new:BackboneElement)
Element `MedicationKnowledge.indicationGuideline.dosingGuideline` has a context of MedicationKnowledge.administrationGuidelines based on following the parent source element upwards and mapping to `MedicationKnowledge`. Element `MedicationKnowledge.indicationGuideline.dosingGuideline` has no mapping targets in FHIR R4. Typically, this is because the element has been added (is a new element).
Dosage for the medication for the specific guidelines
Dosage for the medication for the specific guidelines.
The type of dosage (for example, prophylaxis, maintenance, therapeutic, etc.).
Indication for use that apply to the specific administration guidelines
Indication for use that apply to the specific administration guidelines.
Characteristics of the patient that are relevant to the administration guidelines
Characteristics of the patient that are relevant to the administration guidelines (for example, height, weight, gender, etc.).
Specific characteristic that is relevant to the administration guideline
Specific characteristic that is relevant to the administration guideline (e.g. height, weight, gender).
The specific characteristic (e.g. height, weight, gender, etc.).
Categorization of the medication within a formulary or classification system
Categorization of the medication within a formulary or classification system.
R5: The source of the classification (new)
R5: `MedicationKnowledge.medicineClassification.source[x]` (new:string, uri)
Element `MedicationKnowledge.medicineClassification.source[x]` has a context of MedicationKnowledge.medicineClassification based on following the parent source element upwards and mapping to `MedicationKnowledge`. Element `MedicationKnowledge.medicineClassification.source[x]` has no mapping targets in FHIR R4. Typically, this is because the element has been added (is a new element).
The type of category for the medication (for example, therapeutic classification, therapeutic sub-classification)
The type of category for the medication (for example, therapeutic classification, therapeutic sub-classification).
Specific category assigned to the medication
Specific category assigned to the medication (e.g. anti-infective, anti-hypertensive, antibiotic, etc.).
Information that only applies to packages (not products).
R5: Cost of the packaged medication (new)
R5: `MedicationKnowledge.packaging.cost` (new:MedicationKnowledge.cost)
Element `MedicationKnowledge.packaging.cost` has a context of MedicationKnowledge.packaging based on following the parent source element upwards and mapping to `MedicationKnowledge`. Element `MedicationKnowledge.packaging.cost` has no mapping targets in FHIR R4. Typically, this is because the element has been added (is a new element).
R5: The packaged medication that is being priced (new)
R5: `MedicationKnowledge.packaging.packagedProduct` (new:Reference(PackagedProductDefinition))
Element `MedicationKnowledge.packaging.packagedProduct` has a context of MedicationKnowledge.packaging based on following the parent source element upwards and mapping to `MedicationKnowledge`. Element `MedicationKnowledge.packaging.packagedProduct` has no mapping targets in FHIR R4. Typically, this is because the element has been added (is a new element).
A code that defines the specific type of packaging that the medication can be found in
A code that defines the specific type of packaging that the medication can be found in (e.g. blister sleeve, tube, bottle).
A coded concept defining the type of packaging of a medication.
The number of product units the package would contain if fully loaded
The number of product units the package would contain if fully loaded.
Specifies descriptive properties of the medicine
Specifies descriptive properties of the medicine, such as color, shape, imprints, etc.
R5: Definitional resources that provide more information about this medication (new)
R5: `MedicationKnowledge.definitional.definition` (new:Reference(MedicinalProductDefinition))
Element `MedicationKnowledge.definitional.definition` has a context of MedicationKnowledge.drugCharacteristic based on following the parent source element upwards and mapping to `MedicationKnowledge`. Element `MedicationKnowledge.definitional.definition` has no mapping targets in FHIR R4. Typically, this is because the element has been added (is a new element).
R5: `MedicationKnowledge.definitional.drugCharacteristic.value[x]` additional types (Attachment)
Element `MedicationKnowledge.definitional.drugCharacteristic.value[x]` is mapped to FHIR R4 element `MedicationKnowledge.drugCharacteristic.value[x]` as `SourceIsBroaderThanTarget`. The mappings for `MedicationKnowledge.definitional.drugCharacteristic.value[x]` do not cover the following types: Attachment. The target context `MedicationKnowledge.drugCharacteristic.value[x]` is a choice-type element and cannot directly hold extensions. The context is moved up to parent element `MedicationKnowledge.drugCharacteristic`. The description should be provided as a CodeableConcept, SimpleQuantity or an image. The description can be a string only when these others are not available.
Code specifying the type of characteristic of medication
A code specifying which characteristic of the medicine is being described (for example, colour, shape, imprint).
A coded concept defining the characteristic types of a medication.
The description should be provided as a CodeableConcept, SimpleQuantity or an image. The description can be a string only when these others are not available.
Potential clinical issue with or between medication(s)
Potential clinical issue with or between medication(s) (for example, drug-drug interaction, drug-disease contraindication, drug-allergy interaction, etc.).
R5: `MedicationKnowledge.clinicalUseIssue` additional types from child elements (display, identifier, reference, type)
Element `MedicationKnowledge.clinicalUseIssue` is mapped to FHIR R4 element `MedicationKnowledge.contraindication` as `SourceIsBroaderThanTarget`. The mappings for `MedicationKnowledge.clinicalUseIssue` do not cover the following types based on type expansion: display, identifier, reference, type. The standard extension `alternate-reference` has been mapped as the representation of FHIR R5 element `MedicationKnowledge.clinicalUseIssue` with unmapped reference targets: ClinicalUseDefinition.
Regulatory information about a medication
Regulatory information about a medication.
Specifies the authority of the regulation
The authority that is specifying the regulations.
Specifies if changes are allowed when dispensing a medication from a regulatory perspective
Specifies if changes are allowed when dispensing a medication from a regulatory perspective.
Specifies the type of substitution allowed
Specifies the type of substitution allowed.
Specifies if regulation allows for changes in the medication when dispensing
Specifies if regulation allows for changes in the medication when dispensing.
Specifies the schedule of a medication in jurisdiction
Specifies the schedule of a medication in jurisdiction.
The maximum number of units of the medication that can be dispensed in a period
The maximum number of units of the medication that can be dispensed in a period.
The maximum number of units of the medication that can be dispensed
The maximum number of units of the medication that can be dispensed.
The period that applies to the maximum number of units
The period that applies to the maximum number of units.
The time course of drug absorption, distribution, metabolism and excretion of a medication from the body
The time course of drug absorption, distribution, metabolism and excretion of a medication from the body.
The drug concentration measured at certain discrete points in time
The drug concentration measured at certain discrete points in time.
Time required for concentration in the body to decrease by half
The time required for any specified property (e.g., the concentration of a substance in the body) to decrease by half.
R5: active | entered-in-error | inactive
Element `MedicationKnowledge.status` is mapped to FHIR R4 element `MedicationKnowledge.status` as `Equivalent`. An externally-defined extension that has been mapped as the representation of FHIR R5 element `MedicationKnowledge.status`: `http://hl7.org/fhir/StructureDefinition/artifact-status`. This status is intended to identify if the medication in a local system is in active use within a drug database or inventory. For example, a pharmacy system may create a new drug file record for a compounded product "ABC Hospital Special Cream" with an active status. At some point in the future, it may be determined that the drug record was created with an error and the status is changed to "entered in error". This status is not intended to specify if a medication is part of a particular formulary. It is possible that the drug record may be referenced by multiple formularies or catalogues and each of those entries would have a separate status.